QQQ   315.65 (-2.62%)
AAPL   122.00 (-2.67%)
MSFT   230.22 (-1.85%)
FB   257.31 (-2.65%)
GOOGL   2,027.96 (-2.68%)
AMZN   3,089.19 (-2.23%)
TSLA   700.35 (-5.62%)
NVDA   536.88 (-7.43%)
BABA   242.49 (-3.14%)
CGC   33.80 (-5.06%)
GE   12.82 (-2.29%)
MU   89.34 (-3.44%)
NIO   47.89 (-7.66%)
AMD   82.92 (-4.62%)
T   28.65 (-2.48%)
F   11.87 (-3.26%)
ACB   11.05 (-5.07%)
DIS   192.59 (-2.49%)
BA   219.48 (-4.30%)
NFLX   539.50 (-2.51%)
BAC   36.03 (-0.96%)
QQQ   315.65 (-2.62%)
AAPL   122.00 (-2.67%)
MSFT   230.22 (-1.85%)
FB   257.31 (-2.65%)
GOOGL   2,027.96 (-2.68%)
AMZN   3,089.19 (-2.23%)
TSLA   700.35 (-5.62%)
NVDA   536.88 (-7.43%)
BABA   242.49 (-3.14%)
CGC   33.80 (-5.06%)
GE   12.82 (-2.29%)
MU   89.34 (-3.44%)
NIO   47.89 (-7.66%)
AMD   82.92 (-4.62%)
T   28.65 (-2.48%)
F   11.87 (-3.26%)
ACB   11.05 (-5.07%)
DIS   192.59 (-2.49%)
BA   219.48 (-4.30%)
NFLX   539.50 (-2.51%)
BAC   36.03 (-0.96%)
QQQ   315.65 (-2.62%)
AAPL   122.00 (-2.67%)
MSFT   230.22 (-1.85%)
FB   257.31 (-2.65%)
GOOGL   2,027.96 (-2.68%)
AMZN   3,089.19 (-2.23%)
TSLA   700.35 (-5.62%)
NVDA   536.88 (-7.43%)
BABA   242.49 (-3.14%)
CGC   33.80 (-5.06%)
GE   12.82 (-2.29%)
MU   89.34 (-3.44%)
NIO   47.89 (-7.66%)
AMD   82.92 (-4.62%)
T   28.65 (-2.48%)
F   11.87 (-3.26%)
ACB   11.05 (-5.07%)
DIS   192.59 (-2.49%)
BA   219.48 (-4.30%)
NFLX   539.50 (-2.51%)
BAC   36.03 (-0.96%)
QQQ   315.65 (-2.62%)
AAPL   122.00 (-2.67%)
MSFT   230.22 (-1.85%)
FB   257.31 (-2.65%)
GOOGL   2,027.96 (-2.68%)
AMZN   3,089.19 (-2.23%)
TSLA   700.35 (-5.62%)
NVDA   536.88 (-7.43%)
BABA   242.49 (-3.14%)
CGC   33.80 (-5.06%)
GE   12.82 (-2.29%)
MU   89.34 (-3.44%)
NIO   47.89 (-7.66%)
AMD   82.92 (-4.62%)
T   28.65 (-2.48%)
F   11.87 (-3.26%)
ACB   11.05 (-5.07%)
DIS   192.59 (-2.49%)
BA   219.48 (-4.30%)
NFLX   539.50 (-2.51%)
BAC   36.03 (-0.96%)
Log in
NYSE:GMED

Globus Medical Stock Forecast, Price & News

$62.12
-1.28 (-2.02 %)
(As of 02/25/2021 01:27 PM ET)
Add
Compare
Today's Range
$61.74
Now: $62.12
$63.66
50-Day Range
$61.39
MA: $64.77
$67.74
52-Week Range
$33.41
Now: $62.12
$68.24
Volume6,909 shs
Average Volume479,441 shs
Market Capitalization$6.13 billion
P/E Ratio67.52
Dividend YieldN/A
Beta1.02
Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP37957720
Phone610-930-1800
Employees2,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$785.37 million
Cash Flow$2.11 per share
Book Value$14.05 per share

Profitability

Net Income$155.21 million

Miscellaneous

Market Cap$6.13 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.57 out of 5 stars

Medical Sector

347th out of 1,958 stocks

Surgical & Medical Instruments Industry

30th out of 168 stocks

Analyst Opinion: 2.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -
$62.12
-1.28 (-2.02 %)
(As of 02/25/2021 01:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GMED News and Ratings via Email

Sign-up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Globus Medical (NYSE:GMED) Frequently Asked Questions

Is Globus Medical a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Globus Medical stock.
View analyst ratings for Globus Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Globus Medical?

Wall Street analysts have given Globus Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Globus Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Globus Medical's next earnings date?

Globus Medical is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Globus Medical
.

How were Globus Medical's earnings last quarter?

Globus Medical, Inc. (NYSE:GMED) posted its quarterly earnings results on Tuesday, February, 16th. The medical device company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Globus Medical had a trailing twelve-month return on equity of 9.85% and a net margin of 12.36%.
View Globus Medical's earnings history
.

How has Globus Medical's stock been impacted by Coronavirus (COVID-19)?

Globus Medical's stock was trading at $38.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GMED shares have increased by 64.3% and is now trading at $62.50.
View which stocks have been most impacted by COVID-19
.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, February, 17th. The company provided earnings per share (EPS) guidance of 1.83-1.83 for the period, compared to the Thomson Reuters consensus estimate of $2.01. The company issued revenue guidance of $880-880 million, compared to the consensus revenue estimate of $914.22 million.

What price target have analysts set for GMED?

14 brokers have issued 12-month price targets for Globus Medical's shares. Their forecasts range from $56.00 to $77.00. On average, they anticipate Globus Medical's share price to reach $66.40 in the next year. This suggests a possible upside of 6.2% from the stock's current price.
View analysts' price targets for Globus Medical
or view top-rated stocks among Wall Street analysts.

Who are Globus Medical's key executives?

Globus Medical's management team includes the following people:
  • Mr. David C. Paul, Co-Founder & Exec. Chairman (Age 54, Pay $956.45k)
  • Mr. David M. Demski, CEO, Pres & Director (Age 63, Pay $1.47M)
  • Mr. Keith W. Pfeil, Sr. VP & CFO (Age 42, Pay $405.66k)
  • Ms. Kelly G. Huller, Sr. VP, Gen. Counsel & Sec. (Age 49, Pay $441.62k)
  • Mr. Daniel T. Scavilla, Exec. VP & Chief Commercial Officer (Age 56, Pay $851.28k)
  • Mr. Brian J. Kearns, Sr. VP of Bus. Devel. & Investor Relations (Age 54)
  • Mr. A. Brett Murphy, Exec. VP of International Sales (Age 56)
  • Mr. Steven M. Payne, VP & Controller (Age 50)
  • Mr. Mike Reeder, Exec. Officer
  • Mr. Richard Holifield, Exec. Officer

What is David Demski's approval rating as Globus Medical's CEO?

47 employees have rated Globus Medical CEO David Demski on Glassdoor.com. David Demski has an approval rating of 61% among Globus Medical's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Globus Medical's key competitors?

What other stocks do shareholders of Globus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), The Trade Desk (TTD), Square (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA).

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

Who are Globus Medical's major shareholders?

Globus Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.51%), Janus Henderson Group PLC (6.53%), Van Berkom & Associates Inc. (1.59%), GW&K Investment Management LLC (1.44%), Price T Rowe Associates Inc. MD (0.89%) and Bank of New York Mellon Corp (0.83%). Company insiders that own Globus Medical stock include Anthony L Williams, David D Davidar, David M Demski, James R Tobin, Kelly Huller and Robert Andrew Douglas.
View institutional ownership trends for Globus Medical
.

Which major investors are selling Globus Medical stock?

GMED stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Fort Washington Investment Advisors Inc. OH, Engineers Gate Manager LP, Marathon Asset Management LLP, First Trust Advisors LP, ExodusPoint Capital Management LP, Aviva PLC, and Sterling Investment Advisors Ltd.. Company insiders that have sold Globus Medical company stock in the last year include David D Davidar, David M Demski, James R Tobin, and Kelly Huller.
View insider buying and selling activity for Globus Medical
or view top insider-selling stocks.

Which major investors are buying Globus Medical stock?

GMED stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Nicholas Company Inc., Pembroke Management LTD, Assenagon Asset Management S.A., Janus Henderson Group PLC, Nordea Investment Management AB, GW&K Investment Management LLC, and JPMorgan Chase & Co..
View insider buying and selling activity for Globus Medical
or or view top insider-buying stocks.

How do I buy shares of Globus Medical?

Shares of GMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Globus Medical's stock price today?

One share of GMED stock can currently be purchased for approximately $62.50.

How much money does Globus Medical make?

Globus Medical has a market capitalization of $6.17 billion and generates $785.37 million in revenue each year. The medical device company earns $155.21 million in net income (profit) each year or $1.68 on an earnings per share basis.

How many employees does Globus Medical have?

Globus Medical employs 2,000 workers across the globe.

What is Globus Medical's official website?

The official website for Globus Medical is www.globusmedical.com.

Where are Globus Medical's headquarters?

Globus Medical is headquartered at 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The medical device company can be reached via phone at 610-930-1800 or via email at [email protected]


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.